Latest Healthcare Research Reports

Tag: DNA and gene chip market trends

  • 2024-2033 Global DNA And Gene Chip Market Outlook: Projected Size and Growth Rate

    2024-2033 Global DNA And Gene Chip Market Outlook: Projected Size and Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    DNA And Gene Chip Market Growth Forecast 2024-2033: What’s the Expected Rate?

    There has been a swift expansion in the market size of dna and gene chips in the recent past. It is projected to escalate from $7.38 billion in 2023 to $8.4 billion in 2024, experiencing a compound annual growth rate (CAGR) of 13.9%. Factors such as progress in genomic research, the emergence of personalized medicine, breakthroughs in the human genome project, advancements in drug discovery and development, and identification of disease biomarkers have contributed to the historic period’s growth.

    Anticipated to experience swift expansion in the coming years, the dna and gene chip market is predicted to reach $13.7 billion in 2028, with an impressive compound annual growth rate (CAGR) of 13.0%. The factors driving this growth during the forecast period include the progression of precision medicine, broadening of biomarker discovery, burgeoning of personalized therapeutics, application within cancer research, and upsurge in research fund allocation. Key trends for the forecast period encompass advancements in technology, innovations in products, regulatory rules and adherence, concentration on rare diseases, and continual cost reduction.

    Claim Your Free Sample of the Global DNA And Gene Chip Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

    What Factors Are Impacting the Growth of the dna and gene chip Market?

    The escalating need for early diagnosis of cancer is playing a considerable role in the expansion of the DNA and gene industry. Cancer incarnates as a wide category of diseases, potentially arising in any tissue or organ of the body, caused by anomalous cell multiplication that surpasses normal boundaries to invade adjacent organs and disseminates to other areas of the body. DNA and gene microarrays are employed to gauge gene expression designs, comprehend the genetical and epigenetical outlook, and evaluate genomic regulatory components bound by cancer’s vital regulatory proteins in cancer cells. For example, the American Cancer Society, a U.S. based voluntary health organization, predicts that in 2022, there will be around 1.9 million fresh cancer diagnoses and 609,360 cancer fatalities within the United States. Thus, the increasing necessity for early cancer diagnosis is fueling the expansion of the DNA and gene chip sector.

    What Are the Fundamental Segments in the DNA And Gene Chip Market?

    1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types

    2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications

    3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

    What Trends Are Shaping the New Direction of the DNA And Gene Chip Market?

    The trend of strategic alliances and cooperative endeavors is increasingly prominent in the DNA and gene chip market. Numerous corporations within the field are seeking such collaborations to fortify their stronghold in the market. A case in point is the June 2022 collaboration between Avesthagen Limited, an India-based integrated systems biology platform company, and Wipro Limited, an India-based IT firm. Post this four-year strategic alliance, both companies have embarked on a venture titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA, predominantly about genomics sequencing services related to lung cancer. Another noteworthy alliance initiated in May 2022 is between Thermo Fisher Scientific, an analytical instruments supplier from the US, and Qatar Genome Program (QGP) – a Qatar Foundation (QF) member. The aim of this partnership is to create an Axiom custom genotyping array for pan-Arab populations using the whole genome sequencing information from 19 Arab nations. The goal is to compile an array comprising 800,000 variants, focusing on improving genomic research on conditions like diabetes, cardiovascular diseases, autism, and cancer. This joint endeavor aligns with Qatar’s national vision to boost population health and drives the progression of precision medicine for the global Arab population. Thermo Fisher’s Axiom microarray technology is a vital enabler for these fast-paced precision medicine advancements.

    Order Now for Fast Delivery of Your DNA And Gene Chip Market Report!

    https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

    North America was the largest region in the DNA and gene chip market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The DNA And Gene Chip Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the dna and gene chip market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The DNA And Gene Chip Market Include

    1. DNA And Gene Chip Market Executive Summary

    2. DNA And Gene Chip Market Segments

    3. DNA And Gene Chip Market Size And Template Market Growth Rate

    4. Key DNA And Gene Chip Market Trends

    5. Major DNA And Gene Chip Market Drivers

    ……

    25. Key Mergers And Acquisitions In The DNA And Gene Chip Market

    26. Top DNA And Gene Chip Companies

    27. DNA And Gene Chip Market Opportunities And Strategies

    28. DNA And Gene Chip Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Wireless Telecommunication Carriers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/construction-global-market-report

    5G Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/5g-services-global-market-report

    5G Infrastructure Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/5g-infrastructure-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What Will The DNA And Gene Chip Market Look Like In 2023?

    What Will The DNA And Gene Chip Market Look Like In 2023?

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

    The Business Research Company’s DNA and gene chip market report forecasts the DNA and gene chip market size to grow to $11.71 Billion by 2027, with a CAGR (compound annual growth rate) of more than 12%.

    Learn More On The DNA And Gene Chip Market Report 2023 – https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

    DNA And Gene Chip Market Size Forecast
    The global DNA and gene chip market is expected to grow from $6.47 billion in 2022 to $7.33 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The DNA and gene chip market size is expected to reach $11.71 billion in 2027 at a CAGR of 12.4%.

    North America held the largest DNA and gene chip market share, and Asia-Pacific was the fastest-growing region in 2022.

    Key DNA And Gene Chip Market Driver ­– Rise In Demand For Early Cancer Detection
    For instance, according to the Switzerland-based non-governmental organization Union for International Cancer Control (UICC)’s GLOBOCAN 2020: New Global Cancer Data published in December 2020, there were 10.3 million cancer deaths and 19.3 million new cases worldwide in 2020. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.

    Request for A Sample Of The Global DNA And Gene Chip Market Report:
    https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

    Key DNA And Gene Chip Market Trend – Strategic Partnerships And Collaborations
    Many companies operating in this sector looking for partnerships to strengthen their position in the DNA and gene chip market. For instance, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, entered into a four-year strategic partnership with Wipro Limited, an India-based information technology company. Through this partnership, both companies execute the project titled cancer risk assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Further, in January 2020, Illumina Inc., a US-based biotechnology company involved in DNA sequencing and array-based technologies, partnered with Roche, a Switzerland-based pharmaceuticals and diagnostics company. This partnership brings together complementary capabilities of each company to broaden the global adoption of NGS in cancer care. Roche receives rights from Illumina to create and market in-vitro diagnostic (IVD) tests on Illumina’s NextSeq 550Dx System and its future portfolio of diagnostic (Dx) sequencing systems, including the forthcoming NovaSeqDx.

    DNA And Gene Chip Market Segment
    1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
    2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
    3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

    DNA And Gene Chip Market Major Players and Strategies
    Major players in the DNA and gene chip market are Perkin Elmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology, Affymetrix Inc., Bioneer Corp., and Eurofins Mwg Operon.

    In October 2021, Schott Minifab, an Australia-based manufacturer of microfluidic and medical devices, acquired Applied Microarrays Inc. for an undisclosed amount. This acquisition is expected to strengthen Schott’s bioscience capabilities and expand its biosensor printing capabilities. Microarrays Inc. is a US-based DNA microarray manufacturing company that develops DNA and protein biosensors and other microarrays.

    The DNA And Gene Chip Global Market Report 2023 covers regional data on DNA and gene chip market size, DNA and gene chip market trends and drivers, opportunities, strategies, and DNA and gene chip market competitor analysis. The countries covered in the DNA and gene chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

    A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person’s DNA has mutations in genes which are variations in DNA which can cause ailments.

    View More Reports Related To The DNA And Gene Chip Market –
    DNA Based Skin Care Products Global Market Report 2023
    Recombinant DNA Technology Global Market Report 2023 –
    Gene Editing Global Market Report 2023

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas     +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info

    Follow us on:
    LinkedIn:     https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
    Found this article helpful? Share it on:

  • What’s The Growth Forecast For DNA And Gene Chip Market Through 2024-2033?

    What’s The Growth Forecast For DNA And Gene Chip Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The DNA and gene chip market has witnessed remarkable growth, driven by various factors such as genomic research advancements, personalized medicine, and the human genome project milestones. Let’s delve into the insights and projections of this burgeoning market.

    Market Growth Trajectory

    • The DNA and gene chip market size surged from $7.38 billion in 2023 to $8.4 billion in 2024, reflecting a notable compound annual growth rate (CAGR) of 13.9%.
    • Forecasts suggest a continued upward trend, with the market projected to reach $13.7 billion by 2028, exhibiting a CAGR of 13.0%.

    Drivers of Growth

    • Advancements in Precision Medicine: Precision medicine, leveraging genetic profiles for tailored treatments, emerges as a significant driver.
    • Expansion of Biomarker Discovery: Growing emphasis on biomarker identification amplifies the demand for DNA and gene chips.
    • Application in Cancer Research: The pivotal role of gene chips in cancer research contributes to market expansion.
    • Increasing Research Funding: Enhanced funding for genomic research fuels innovation and market growth.

    Elevated Focus on Personalized Medicine

    • Personalized medicine gains momentum, leveraging genetic insights to inform medical decisions.
    • DNA and gene chips play a pivotal role in analyzing genetic profiles, identifying disease risks, and optimizing treatment strategies.
    • Regulatory approvals for personalized medicines underscore the market’s potential and significance.

    Key Players Shaping the Market

    • Leading companies such as PerkinElmer Inc., Illumina Inc., and Thermo Fisher Scientific Inc. dominate the landscape.
    • Innovation, technological advancements, and strategic collaborations define competitive strategies.

    View More On The DNA And Gene Chip Market Report 2024 – https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

    Revolutionizing the Food Industry with Genotyping Chips

    • Groundbreaking genotyping chips like Axiom YNS_Mol1 emerge to revolutionize insect breeding and sustainable food production.
    • Ÿnsect’s Axiom YNS_Mol1, developed in partnership with Thermo Fisher Scientific, showcases the fusion of technology and sustainability.
    • The chip facilitates genetic analysis, enhancing traits crucial for sustainable food and pet food production.

    Schott Minifab’s Strategic Acquisition

    • Schott Minifab’s acquisition of Applied Microarrays Inc. underscores the market’s consolidation and strategic expansion.
    • The acquisition bolsters bioscience capabilities and amplifies biosensor printing prowess, strengthening market foothold.

    Segmentation Insights

    • The DNA and gene chip market segmentation includes types like Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), among others.
    • Applications span across cancer diagnostics, gene expression, proteomics, genomics, drug discovery, agrigenomics, and more.
    • End users encompass academic and government research institutes, biotechnology and pharmaceutical companies, hospitals and diagnostics centers, and others.

    Regional Dynamics

    • North America leads the DNA and gene chip market, driven by robust research infrastructure and technological innovation.
    • Asia-Pacific emerges as the fastest-growing region, propelled by escalating research initiatives and increasing healthcare investments.

    Conclusion
    The DNA and gene chip market epitomizes innovation, driven by the pursuit of precision medicine, transformative technologies, and sustainable solutions. As the market continues to evolve, stakeholders must navigate dynamic trends and seize opportunities for collaborative advancement and societal impact. Embracing the intersection of genetics, technology, and healthcare, the DNA and gene chip market heralds a future defined by personalized insights, sustainable practices, and enhanced well-being.

    Request A Sample Of The Global DNA And Gene Chip Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=8205&type=smp